Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (181-190 of 349) with videos related to

Pageof 35
Sort By:
Biochemical and Biophysical Research Communications|January 9, 2019
AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathwayBodokhsuren Tsogbadrakh, Hyunjin Ryu, Kyung Don Ju, et al.
International Clinical Psychopharmacology|October 15, 2016
Pharmacokinetics and effect on the corrected QT interval of single-dose escitalopram in healthy elderly compared with younger adultsHyewon Chung, Anhye Kim, Kyoung Soo Lim, et al.
Plos One|February 6, 2014
Investigating the different mechanisms of genotoxic and non-genotoxic carcinogens by a gene set analysisWon Jun Lee, Sang Cheol Kim, Seul Ji Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
Sumin Yoon, Su-Jin Rhee, Sang-In Park, et al.
Cancer Science|October 8, 2024
Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumorJoo Young Na, Juyeun Jeon, Ki Young Huh, et al.
Drugs in R&D|April 3, 2014
The effects of moxifloxacin on QTc interval in healthy Korean male subjectsSeol Ju Moon, Jongtae Lee, Hyungmi An, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 14, 2024
Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysisTyra Nguyen, Katherine Barnhill, Alex Zhornitskiy, et al.
Expert Opinion on Investigational Drugs|March 15, 2017
A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteersKyoung Ryun Park, Hyewon Chung, Sung Mo Yang, et al.
Biopharmaceutics & Drug Disposition|March 29, 2019
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulationYun Kim, Oliver Hatley, Su-Jin Rhee, et al.
Bone Marrow Transplantation|June 20, 2018
Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patientsHyewon Chung, Kyung Taek Hong, Ji Won Lee, et al.
Pageof 35

Showing results (181-190 of 349) with videos related to

Sort By:
Pageof 35
Biochemical and Biophysical Research Communications|January 9, 2019
AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathwayBodokhsuren Tsogbadrakh, Hyunjin Ryu, Kyung Don Ju, et al.
International Clinical Psychopharmacology|October 15, 2016
Pharmacokinetics and effect on the corrected QT interval of single-dose escitalopram in healthy elderly compared with younger adultsHyewon Chung, Anhye Kim, Kyoung Soo Lim, et al.
Plos One|February 6, 2014
Investigating the different mechanisms of genotoxic and non-genotoxic carcinogens by a gene set analysisWon Jun Lee, Sang Cheol Kim, Seul Ji Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
Sumin Yoon, Su-Jin Rhee, Sang-In Park, et al.
Cancer Science|October 8, 2024
Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumorJoo Young Na, Juyeun Jeon, Ki Young Huh, et al.
Drugs in R&D|April 3, 2014
The effects of moxifloxacin on QTc interval in healthy Korean male subjectsSeol Ju Moon, Jongtae Lee, Hyungmi An, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 14, 2024
Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysisTyra Nguyen, Katherine Barnhill, Alex Zhornitskiy, et al.
Expert Opinion on Investigational Drugs|March 15, 2017
A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteersKyoung Ryun Park, Hyewon Chung, Sung Mo Yang, et al.
Biopharmaceutics & Drug Disposition|March 29, 2019
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulationYun Kim, Oliver Hatley, Su-Jin Rhee, et al.
Bone Marrow Transplantation|June 20, 2018
Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patientsHyewon Chung, Kyung Taek Hong, Ji Won Lee, et al.
Pageof 35